Cliff Asness's ZBH Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 323,720 shares of Zimmer Biomet Holdings, Inc. (ZBH) worth $29.11 M, representing 0.02% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 53 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in ZBH, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2025, adding 955,284 shares. Largest reduction occurred in Q4 2025, reducing 606,179 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Zimmer Biomet Holdings (ZBH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Zimmer Biomet Holdings (ZBH) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -606,179 | Reduce 65.19% | 323,720 | $89.92 |
| Q3 2025 | -370,694 | Reduce 28.50% | 929,899 | $98.50 |
| Q2 2025 | +955,284 | Add 276.65% | 1.3 M | $91.21 |
| Q1 2025 | -77,371 | Reduce 18.30% | 345,309 | $112.25 |
| Q4 2024 | +878 | Add 0.21% | 422,680 | $105.63 |
| Q3 2024 | +1,023 | Add 0.24% | 421,802 | $107.60 |
| Q2 2024 | +7,358 | Add 1.78% | 420,779 | $107.80 |
| Q1 2024 | -34,500 | Reduce 7.70% | 413,421 | $131.98 |
| Q4 2023 | +34,147 | Add 8.25% | 447,921 | $121.70 |
| Q3 2023 | +194,715 | Add 88.89% | 413,774 | $112.22 |
| Q2 2023 | +46,787 | Add 27.16% | 219,059 | $145.60 |
| Q1 2023 | +19,428 | Add 12.71% | 172,272 | $128.27 |
| Q4 2022 | +15,626 | Add 11.39% | 152,844 | $127.10 |
| Q3 2022 | +22,455 | Add 19.57% | 137,218 | $104.55 |
| Q2 2022 | -11,692 | Reduce 9.25% | 114,763 | $103.56 |
| Q1 2022 | -6,984 | Reduce 5.23% | 126,455 | $127.90 |
| Q4 2021 | +19,845 | Add 17.47% | 133,439 | $123.34 |
| Q3 2021 | +19,230 | Add 20.38% | 113,594 | $142.09 |
| Q2 2021 | +21,647 | Add 29.77% | 94,364 | $156.14 |
| Q1 2021 | +24,301 | Add 50.19% | 72,717 | $155.41 |
| Q4 2020 | -73,680 | Reduce 60.35% | 48,416 | $149.60 |
| Q3 2020 | -138,809 | Reduce 53.20% | 122,096 | $132.17 |
| Q2 2020 | +13,249 | Add 5.35% | 260,905 | $113.01 |
| Q1 2020 | +99,003 | Add 66.60% | 247,656 | $96.13 |
| Q4 2019 | +45,772 | Add 44.49% | 148,653 | $145.32 |
| Q3 2019 | -89,736 | Reduce 46.59% | 102,881 | $133.27 |
| Q2 2019 | +18,066 | Add 10.35% | 192,617 | $111.65 |
| Q1 2019 | +113,098 | Add 184.04% | 174,551 | $122.96 |
| Q4 2018 | +50,058 | Add 439.30% | 61,453 | $100.69 |
| Q3 2018 | -3,217 | Reduce 22.02% | 11,395 | $127.60 |
| Q2 2018 | -98,974 | Reduce 87.14% | 14,612 | $108.20 |
| Q1 2018 | -68,191 | Reduce 37.51% | 113,586 | $105.87 |
| Q4 2017 | +32,820 | Add 22.03% | 181,777 | $117.15 |
| Q3 2017 | -53,211 | Reduce 26.32% | 148,957 | $113.68 |
| Q2 2017 | +184,685 | Add 1056.37% | 202,168 | $124.66 |
| Q1 2017 | -6,860 | Reduce 28.18% | 17,483 | $118.57 |
| Q4 2016 | -82,172 | Reduce 77.15% | 24,343 | $100.19 |
| Q3 2016 | +9,407 | Add 9.69% | 106,515 | $126.24 |
| Q2 2016 | -11,347 | Reduce 10.46% | 97,108 | $116.87 |
| Q1 2016 | -24,014 | Reduce 18.13% | 108,455 | $103.53 |
| Q4 2015 | -2,472 | Reduce 1.83% | 132,469 | $99.60 |
| Q3 2015 | -215,974 | Reduce 61.55% | 134,941 | $91.20 |
| Q2 2015 | -150,333 | Reduce 29.99% | 350,915 | $106.05 |
| Q1 2015 | -128,399 | Reduce 20.39% | 501,248 | $114.10 |
| Q4 2014 | -99,979 | Reduce 13.70% | 629,647 | $110.12 |
| Q3 2014 | +47,366 | Add 6.94% | 729,626 | $97.62 |
| Q2 2014 | +122,982 | Add 21.99% | 682,260 | $100.84 |
| Q1 2014 | +133,488 | Add 31.35% | 559,278 | $91.83 |
| Q4 2013 | -32,738 | Reduce 7.14% | 425,790 | $90.48 |
| Q3 2013 | -200,846 | Reduce 30.46% | 458,528 | $79.75 |
| Q2 2013 | +659,374 | Add 0.00% | 659,374 | $72.76 |
| Q4 2012 | +1.03 M | Add 0.00% | 1.03 M | $64.72 |
Cliff Asness's Zimmer Biomet Holdings Investment FAQs
Cliff Asness first purchased Zimmer Biomet Holdings, Inc. (ZBH) in Q4 2012, acquiring 1,028,724 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Zimmer Biomet Holdings, Inc. (ZBH) for 53 quarters since Q4 2012.
Cliff Asness's largest addition to Zimmer Biomet Holdings, Inc. (ZBH) was in Q4 2012, adding 1,028,724 shares worth $66.58 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 323,720 shares of Zimmer Biomet Holdings, Inc. (ZBH), valued at approximately $29.11 M.
As of the Q4 2025 filing, Zimmer Biomet Holdings, Inc. (ZBH) represents approximately 0.02% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Zimmer Biomet Holdings, Inc. (ZBH) was 1,300,593 shares, as reported at the end of Q2 2025.